Jeff Sternlicht: Inflammation is The ‘Storm’ Before Atherosclerosis
Jeff Sternlicht, Emergency Physician and Medical Director at Vituity, shared a post on LinkedIn:
“Atherosclerosis is not just a cholesterol problem. It’s also an inflammation problem.
We’ve gotten very good at measuring and treating LDL and Аров.
And that matters.
But there’s another layer of risk that often goes unmeasured.
Inflammation.
hsCRP is a simple blood test that can detect that ‘storm’ long before symptoms, long before an event.
Levels above ~2 mg/L should make us pause and look deeper.
What’s becoming more clear is that even when LDL and ApoB are well controlled, residual inflammatory risk can persist.
This hasn’t always been part of routine screening, but it’s now being recognized more explicitly in newer guidelines.
In my own case, this was a major blind spot.
Lowering ApoB mattered.
But addressing inflammation changed my trajectory.
If we’re not measuring inflammation, we’re not seeing the full picture of risk.
Disclaimer:
Views are my own and not those of my employer or affiliates.
This is for educational purposes only and not medical advice.”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke